Correlation Between Nurix Therapeutics and Immunovant

Can any of the company-specific risk be diversified away by investing in both Nurix Therapeutics and Immunovant at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nurix Therapeutics and Immunovant into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nurix Therapeutics and Immunovant, you can compare the effects of market volatilities on Nurix Therapeutics and Immunovant and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nurix Therapeutics with a short position of Immunovant. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nurix Therapeutics and Immunovant.

Diversification Opportunities for Nurix Therapeutics and Immunovant

0.4

Correlation Coefficient

Nurix Therapeutics  Immunovant

Very weak diversification

The 3 months correlation between Nurix and Immunovant is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding Nurix Therapeutics and Immunovant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Immunovant and Nurix Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nurix Therapeutics are associated (or correlated) with Immunovant. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Immunovant has no effect on the direction of Nurix Therapeutics i.e., Nurix Therapeutics and Immunovant go up and down completely randomly.

Pair Corralation between Nurix Therapeutics and Immunovant

Given the investment horizon of 90 days Nurix Therapeutics is expected to under-perform the Immunovant. In addition to that, Nurix Therapeutics is 1.21 times more volatile than Immunovant. It trades about -0.04 of its total potential returns per unit of risk. Immunovant is currently generating about -0.03 per unit of volatility. If you would invest  3,046  in Immunovant on September 2, 2024 and sell it today you would lose (226.00) from holding Immunovant or give up 7.42% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Nurix Therapeutics  vs.  Immunovant

Nurix Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Nurix Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Immunovant

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Immunovant has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Immunovant is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Nurix Therapeutics and Immunovant

The main advantage of trading using opposite Nurix Therapeutics and Immunovant positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nurix Therapeutics position performs unexpectedly, Immunovant can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immunovant will offset losses from the drop in Immunovant's long position.

The idea behind Nurix Therapeutics and Immunovant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.